US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Distillate Small/Mid Cash Flow ETF

38.26

-0.1825-0.47%

Volume:863.00

Turnover:33.08K

Market Cap:123.39M

PE:- -

High:38.26

Open:38.26

Low:38.26

Close:38.44

52wk High:39.21

52wk Low:26.93

Shares:3.23M

Float Shares:3.23M

Volume Ratio:0.20

T/O Rate:0.03%

Dividend:0.42

Dividend Rate:1.09%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Radiopharm Theranostics Says Cash And Cash Equivalents Of Approximately $34.52m For Or The 6 Months Ended December 31, 2025 Provide Runway Into 2027

Press Release: Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration

Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation

Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs

Radiopharm receives DSMC recommendation to advance Phase 1 ‘HEAT’ trial

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial

Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/DSMC/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DSMC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSMC\",,,,,undefined,":{"symbol":"DSMC","market":"US","secType":"STK","nameCN":"Distillate Small/Mid Cash Flow ETF","latestPrice":38.26,"timestamp":1771520274747,"preClose":38.4425,"halted":0,"volume":863,"delay":0,"changeRate":-0.0047473499382195364,"floatShares":3225000,"shares":3225000,"eps":0,"marketStatus":"Trading","change":-0.1825,"latestTime":"02-19 12:07:48 EST","open":38.26,"high":38.26,"low":38.26,"amount":33084.733480999996,"amplitude":0,"askPrice":38.34,"askSize":800,"bidPrice":38.3,"bidSize":700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1771534800000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":38.4425,"sharesOutstanding":3225000,"nav":38.19,"aum":123162750,"dividendRate":0.01093,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":38.44,"preClose":38.4425,"latestTime":"16:10 EST","volume":48,"amount":1842.74,"timestamp":1771449008775,"change":-0.0025,"changeRate":-0.000065,"amplitude":0},"volumeRatio":0.202447,"impliedVol":0.142,"impliedVolPercentile":0.6154},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DSMC\",,,,,undefined,":{"symbol":"DSMC","floatShares":3225000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.202447,"shares":3225000,"dividePrice":0.4182,"high":38.26,"amplitude":0,"preClose":38.4425,"low":38.26,"week52Low":26.93,"pbRate":"--","week52High":39.2089,"institutionHeld":0,"latestPrice":38.26,"committee":-0.066667,"eps":0,"divideRate":0.01093,"volume":863,"delay":0,"ttmEps":0,"open":38.26,"prevYearClose":35.47,"prevWeekClose":38.3676,"prevMonthClose":37.69,"prevQuarterClose":35.47,"fiveDayClose":38.8,"twentyDayClose":37.93,"sixtyDayClose":32.9469},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DSMC\",params:#limit:5,,,undefined,":[{"date":"2025-12-29","symbol":"DSMC","amount":0.15085733,"announcedDate":"2025-12-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-29","defaultRemindTime":1767018600000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-30","payableDate":"2025-12-29","currency":"USD","dateTimestamp":1766984400000,"payDate":"2025-12-30"},{"date":"2025-09-24","symbol":"DSMC","amount":0.08622672,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-25","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-25"},{"date":"2025-06-25","symbol":"DSMC","amount":0.1076,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-26","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-06-26"},{"date":"2025-03-26","symbol":"DSMC","amount":0.075599,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-27","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-03-27"},{"date":"2024-12-27","symbol":"DSMC","amount":0.16,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-27","defaultRemindTime":1735309800000,"name":"Distillate Small/Mid Cash Flow ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-27","currency":"USD","dateTimestamp":1735275600000,"payDate":"2024-12-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DSMC\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.073726,"currency":"USD"},{"executeDate":"2023-03-22","recordDate":"2023-03-23","paymentDate":"2023-03-24","value":0.069972,"currency":"USD"},{"executeDate":"2023-06-21","recordDate":"2023-06-22","paymentDate":"2023-06-23","value":0.089299,"currency":"USD"},{"executeDate":"2023-09-20","recordDate":"2023-09-21","paymentDate":"2023-09-22","value":0.086071,"currency":"USD"},{"executeDate":"2023-12-27","recordDate":"2023-12-28","paymentDate":"2023-12-29","value":0.107254,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DSMC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DSMC\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2606151727","title":"Radiopharm Theranostics Says Cash And Cash Equivalents Of Approximately $34.52m For Or The 6 Months Ended December 31, 2025 Provide Runway Into 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2606151727","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606151727?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:09","pubTimestamp":1769602148,"startTime":"0","endTime":"0","summary":"Program and Business Updates18F-RAD101 – Small molecule targeting fatty acid synthase radiolabeled with Fluorine-18RAD 101 is being evaluated in a single-arm U.S. Phase 2b clinical trial for the diagnostic performance of","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/01/50184651/radiopharm-theranostics-says-cash-and-cash-equivalents-of-approximately-34-52m-for-or-the-6-months-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","ODD","BK4213","RADX","IE0009354923.USD","BK4139","SOC","DSMC"],"gpt_icon":0},{"id":"2606715341","title":"Press Release: Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2606715341","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606715341?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:00","pubTimestamp":1769601600,"startTime":"0","endTime":"0","summary":"Interim results from Phase 2b clinical trial of RAD 101 showed 92% of evaluable participants met the primary endpoint of MRI concordance in imaging study of patients with brain metastases. Interim data from additional Cohorts of the Phase 1 clinical trial of RAD 202 and RAD 204 in advanced solid tumors are expected in mid-2026. Cash and cash equivalents of approximately $34.52 million provide runway into 2027 to advance pipeline of high value radiotherapeutic programs through key clinical and regulatory milestones. RAD 101 is being evaluated in a single-arm U.S. Phase 2b clinical trial for the diagnostic performance of the molecule in 30 individuals with confirmed recurrent brain metastases from solid tumors of different origins. RAD 101 has received U.S. Food and Drug Administration  Fast Track Designation to expedite the review process and help bring the novel imaging small molecule to the over 300,000 patients diagnosed annually in the U.S. with cerebral metastases. The study is cur","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","RAD.AU","ODD","BK4183","DSMC","SOC","BK7067","BK4213"],"gpt_icon":0},{"id":"2584945190","title":"EyePoint Announces Positive Recommendation from Independent Data Safety Monitoring Committee for Pivotal Phase 3 Trials for DURAVYU™ in Wet Age-Related Macular Degeneration","url":"https://stock-news.laohu8.com/highlight/detail?id=2584945190","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584945190?lang=en_us&edition=fundamental","pubTime":"2025-11-19 20:00","pubTimestamp":1763553600,"startTime":"0","endTime":"0","summary":"– No changes in protocol recommended for LUGANO and LUCIA clinical trials – – Masked safety data continues to show no safety signals, consistent with previous clinical trials for DURAVYU – – On track ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/19/3190786/0/en/EyePoint-Announces-Positive-Recommendation-from-Independent-Data-Safety-Monitoring-Committee-for-Pivotal-Phase-3-Trials-for-DURAVYU-in-Wet-Age-Related-Macular-Degeneration.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4141","DSMC","IE00BMPRXR70.SGD","BK4573","IE0004445239.USD","LU2098885051.SGD","BK4575","LU2458330243.SGD","LU0127658192.USD","LU0823434583.USD","LU1880398554.USD","EYPT","LU2458330169.SGD","LU0823434740.USD","LU1316542783.SGD","BK4554","LU2250418816.HKD","LU1852331112.SGD","LU0198837287.USD","LU0109392836.USD","LU1303367103.USD","LU1951200564.SGD","LU0823421333.USD","LU2931357623.SGD","IE0009356076.USD","BK4532","LU0056508442.USD","LU1923623000.USD","LU1989764664.SGD","BK4007","LU0719512351.SGD","BK4585","LU0823421416.USD","LU1064131342.USD","LU1861558580.USD","BK4512","BK4605","GFS","LU0642271901.SGD","LU0390134368.USD","BK4588","BK4534","LU2054465674.USD","LU0979878070.USD","LU0081259029.USD","LU1951198990.SGD","LU1803068979.SGD","BK4529"],"gpt_icon":1},{"id":"2580216679","title":"Achieve Life Sciences Meets Key Milestones Advancing Cytisinicline NDA for Smoking Cessation","url":"https://stock-news.laohu8.com/highlight/detail?id=2580216679","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580216679?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176600,"startTime":"0","endTime":"0","summary":"120-Day Safety Update Submitted to FDA ORCA-OL Long-Term Safety Trial Successfully ConcludedDSMC Completes Final Review of Cytisinicline, Finds No Drug Safety Concerns  SEATTLE and VANCOUVER, British ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/03/3179264/0/en/Achieve-Life-Sciences-Meets-Key-Milestones-Advancing-Cytisinicline-NDA-for-Smoking-Cessation.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DSMC"],"gpt_icon":0},{"id":"2576072851","title":"Radiopharm Theranostics Provides Positive Clinical Updates Across Four Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2576072851","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576072851?lang=en_us&edition=fundamental","pubTime":"2025-10-20 20:00","pubTimestamp":1760961600,"startTime":"0","endTime":"0","summary":"Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results exp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169315/0/en/Radiopharm-Theranostics-Provides-Positive-Clinical-Updates-Across-Four-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4183","RADX","BK4139","SOC","BK4128","BK4213","DSMC","RAD","ODD"],"gpt_icon":0},{"id":"2572399665","title":"Radiopharm receives DSMC recommendation to advance Phase 1 ‘HEAT’ trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572399665","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572399665?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:15","pubTimestamp":1759320946,"startTime":"0","endTime":"0","summary":"Radiopharm (RADX) Theranostics announced that it has received a positive recommendation from the Data Safety and Monitoring Committee to advance it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/radiopharm-receives-dsmc-recommendation-to-advance-phase-1-heat-trial-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/radiopharm-receives-dsmc-recommendation-to-advance-phase-1-heat-trial-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RADX","BK4139","DSMC","HEAT"],"gpt_icon":0},{"id":"2572536060","title":"Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee (DSMC) to Accelerate 177Lu-RAD202 Phase 1 ‘HEAT’ Dose Escalation Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2572536060","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572536060?lang=en_us&edition=fundamental","pubTime":"2025-10-01 20:00","pubTimestamp":1759320000,"startTime":"0","endTime":"0","summary":"Phase 1 study to progress to the next dose level of 75mCi in patients with HER2+ advanced solid tumors, instead of the protocol-planned dose of 40mCiSYDNEY, Oct.  01, 2025  (GLOBE NEWSWIRE) -- Radioph","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/01/3159443/0/en/Radiopharm-Theranostics-Receives-Positive-Recommendation-from-Data-Safety-and-Monitoring-Committee-DSMC-to-Accelerate-177Lu-RAD202-Phase-1-HEAT-Dose-Escalation-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HEAT","RADX","BK4139","AAQC","BK4128","DSMC","RAD"],"gpt_icon":0},{"id":"2571469403","title":"Ocular Therapeutix™ Investor Day to Highlight Exceptional AXPAXLI™ Progress Across SOL Program and Detail Registrational Trial Plans to Pursue a Diabetic Retinopathy Label with a Novel Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2571469403","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571469403?lang=en_us&edition=fundamental","pubTime":"2025-09-30 18:21","pubTimestamp":1759227660,"startTime":"0","endTime":"0","summary":"SOL-1 superiority trial continues to demonstrate outstanding patient retention and protocol adherence, with no new or unexpected safety signals observed to date; topline data on track for 1Q 2026 Even","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/30/3158396/0/en/Ocular-Therapeutix-Investor-Day-to-Highlight-Exceptional-AXPAXLI-Progress-Across-SOL-Program-and-Detail-Registrational-Trial-Plans-to-Pursue-a-Diabetic-Retinopathy-Label-with-a-Nov.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4129","LU0198837287.USD","LU1951200564.SGD","IE00BMPRXN33.USD","LU0889565833.HKD","LU1242518857.USD","LU2250418816.HKD","LU0719512351.SGD","GFS","IE0004445239.USD","BK4588","DSMC","BK4554","LU1803068979.SGD","BK4612","BK4543","LU1861558580.USD","BK4573","LU0642271901.SGD","IE0009356076.USD","LU1852331112.SGD","LU2458330169.SGD","LU1303367103.USD","LU0390134368.USD","LU0081259029.USD","LU1923623000.USD","BK4614","BK4512","BK4534","LU0109392836.USD","LU1064131342.USD","LU1242518931.SGD","VTC","OCUL","IE00BMPRXR70.SGD","LU2065732104.USD","SOL","LU0979878070.USD","LU1951198990.SGD","BK4519","LU1880398554.USD","BK4532","BK4141","PRGS","BK4585","BK4605","LU1316542783.SGD","LU0823434740.USD","LU0082616367.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}]}}